Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

High-Risk International Clones of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Endemic to Indonesian Intensive Care Units: Impact of a Multifaceted Infection Control Intervention Analyzed at the Genomic Level.

Pelegrin AC, Saharman YR, Griffon A, Palmieri M, Mirande C, Karuniawati A, Sedono R, Aditianingsih D, Goessens WHF, van Belkum A, Verbrugh HA, Klaassen CHW, Severin JA.

mBio. 2019 Nov 12;10(6). pii: e02384-19. doi: 10.1128/mBio.02384-19.

2.

Genome-wide characterization of mammalian promoters with distal enhancer functions.

Dao LTM, Galindo-Albarrán AO, Castro-Mondragon JA, Andrieu-Soler C, Medina-Rivera A, Souaid C, Charbonnier G, Griffon A, Vanhille L, Stephen T, Alomairi J, Martin D, Torres M, Fernandez N, Soler E, van Helden J, Puthier D, Spicuglia S.

Nat Genet. 2017 Jul;49(7):1073-1081. doi: 10.1038/ng.3884. Epub 2017 Jun 5.

PMID:
28581502
3.

Dynamic recruitment of Ets1 to both nucleosome-occupied and -depleted enhancer regions mediates a transcriptional program switch during early T-cell differentiation.

Cauchy P, Maqbool MA, Zacarias-Cabeza J, Vanhille L, Koch F, Fenouil R, Gut M, Gut I, Santana MA, Griffon A, Imbert J, Moraes-Cabé C, Bories JC, Ferrier P, Spicuglia S, Andrau JC.

Nucleic Acids Res. 2016 May 5;44(8):3567-85. doi: 10.1093/nar/gkv1475. Epub 2015 Dec 15.

4.

Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers.

Barlaam B, Cosulich S, Delouvrié B, Ellston R, Fitzek M, Germain H, Green S, Hancox U, Harris CS, Hudson K, Lambert-van der Brempt C, Lebraud H, Magnien F, Lamorlette M, Le Griffon A, Morgentin R, Ouvry G, Page K, Pasquet G, Polanska U, Ruston L, Saleh T, Vautier M, Ward L.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5155-62. doi: 10.1016/j.bmcl.2015.10.002. Epub 2015 Oct 9.

PMID:
26475521
5.

High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq.

Vanhille L, Griffon A, Maqbool MA, Zacarias-Cabeza J, Dao LT, Fernandez N, Ballester B, Andrau JC, Spicuglia S.

Nat Commun. 2015 Apr 15;6:6905. doi: 10.1038/ncomms7905.

PMID:
25872643
6.

Integrative analysis of public ChIP-seq experiments reveals a complex multi-cell regulatory landscape.

Griffon A, Barbier Q, Dalino J, van Helden J, Spicuglia S, Ballester B.

Nucleic Acids Res. 2015 Feb 27;43(4):e27. doi: 10.1093/nar/gku1280. Epub 2014 Dec 3.

7.

Divergent transcription is associated with promoters of transcriptional regulators.

Lepoivre C, Belhocine M, Bergon A, Griffon A, Yammine M, Vanhille L, Zacarias-Cabeza J, Garibal MA, Koch F, Maqbool MA, Fenouil R, Loriod B, Holota H, Gut M, Gut I, Imbert J, Andrau JC, Puthier D, Spicuglia S.

BMC Genomics. 2013 Dec 23;14:914. doi: 10.1186/1471-2164-14-914.

8.

Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.

Grange M, Verdeil G, Arnoux F, Griffon A, Spicuglia S, Maurizio J, Buferne M, Schmitt-Verhulst AM, Auphan-Anezin N.

J Immunol. 2013 Oct 1;191(7):3712-24. doi: 10.4049/jimmunol.1300319. Epub 2013 Sep 4.

9.

A comprehensive analysis of gene expression changes provoked by bacterial and fungal infection in C. elegans.

Engelmann I, Griffon A, Tichit L, Montañana-Sanchis F, Wang G, Reinke V, Waterston RH, Hillier LW, Ewbank JJ.

PLoS One. 2011;6(5):e19055. doi: 10.1371/journal.pone.0019055. Epub 2011 May 13.

10.

Is there predictive criteria for transfer of patients to a rehabilitation ward after hip and knee total arthroplasty? Elaboration of French clinical practice guidelines.

Coudeyre E, Lefevre-Colau MM, Griffon A, Camilleri A, Ribinik P, Revel M, Rannou F.

Ann Readapt Med Phys. 2007 Jun;50(5):327-36; 317-26. Epub 2007 Apr 11. Review. English, French.

PMID:
17498832
11.

Tuberculin tine tests on medical wards.

Browder AA, Griffon AL.

Am Rev Respir Dis. 1972 Feb;105(2):299-301. No abstract available.

PMID:
5009806

Supplemental Content

Loading ...
Support Center